Our mission is to translate our platform of genome editing into therapeutics.
Algenscribe is developing a genome editing platform to improve human health. Algenscribe is developing new patented genome editing tools that find applications in the fields of gene and cell therapy and bioproduction. Our mission is to reach the full potential of genome editing.
Genone editing for human health and Gene Therapy
Our mission is to translate our platform of genome editing into therapeutics.
Algenscribe is developing a genome editing platform to improve human health. Algenscribe is developing new patented genome editing tools that find applications in the fields of gene and cell therapy and bioproduction. Our mission is to reach the full potential of genome editing.
AlgenScribe is a biotechnology company developing a genome editing platform to improve human health.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Invest in Côte d'Azur - Team Nice Côte d'Azur Startup accelerator & VC, International Trade and Development | Invest in Côte d'Azur - Team Nice Côte d'Azur Startup accelerator & VC, International Trade and Development | Other 21 Jan 2025 | | |
![]() La French Tech Côte d'Azur French Tech, IT Services and IT Consulting | La French Tech Côte d'Azur French Tech, IT Services and IT Consulting | Other 24 Sep 2024 | | |
![]() La French Tech Paris-Saclay French Tech, IT Services and IT Consulting | La French Tech Paris-Saclay French Tech, IT Services and IT Consulting | Other 30 Jul 2024 | | |
![]() CEEI Nice Côte d'Azur Government Administration | CEEI Nice Côte d'Azur Government Administration | Other 30 Sep 2024 | | |
![]() France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 18 Jan 2024 | | |
![]() Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 15 Jan 2025 | |